Pharmafile Logo
Pharmafocus logo
Advanced Search

Alvotech

Showing 3 posts of 3 posts found.

Alvotech and JAMP Pharma’s Jamteki gains marketing authorisation from Health Canada

November 15, 2023
Medical Communications Alvotech, Health Canada, JAMP Pharma, Pharmacy, biosimilar

Alvotech and JAMP Pharma have announced that Health Canada has granted JAMP Pharma marketing authorisation for AVT04, a biosimilar to …

News
rasmus-web

Alvotech recruit new CEO from within

August 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alvotech, biotech, drugs, pharma, pharmaceutical

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …

Appointment
screen_shot_2014-03-18_at_08

Pharma manufacturing news in brief

March 18, 2014
Manufacturing and Production Aesica, Alvotech, Codexis/Intrexon, Pluristem, Updates from Bayer

 Bayer says it plans to invest more than €500 million to establish additional manufacturing capacity for its haemophilia drugs at …

News

Latest content

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment

December 6, 2023

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023